The FDA approved Eli Lilly's new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market
WSJ·2026-04-01 23:38

行业动态 - 美国食品药品监督管理局的批准为公司在蓬勃发展的减肥药市场中开辟了新的竞争战线 [1] - 减肥药市场目前正处于繁荣发展阶段 [1] 市场竞争 - 公司即将与竞争对手诺和诺德在减肥药市场的新领域展开竞争 [1]

The FDA approved Eli Lilly's new weight-loss pill, setting up a fight with rival Novo Nordisk over the next front in the booming market - Reportify